Ege University improves patient access to leading-edge healthcare treatment options by joining Clinerion's Patient Network Explorer platform
Ege University Medical Faculty Hospital brings its patients earlier access to leading-edge treatments and medications by joining the international hospital network on Clinerion's Patient Network Explorer platform. On the platform, the university hospital's patients are brought to the attention of researchers and trial sponsors who are recruiting for clinical trials.
BASEL, Switzerland, July 2, 2020 /PRNewswire-PRWeb/ -- Ege University Hospital serves as the largest hospital in the western part of the country, with an 806,000-bed capacity. Beyond Turkey itself, the university hospital provides services throughout the neighboring countries, as well as the Balkans and the Caucasus, with its experienced team and state-of-the-art equipment.
Ege University-Clinerion partnership project is supported by Prof. Necdet Budak, President of Ege University and Prof. Dr. Tuncay Goksel, Chief Physician of Ege University Hospital. "Clinerion provides a way for us to use our own patient data more efficiently," says Dr. Ersin Koylu, project leader. "This will bring more clinical trials to the university and it will make the clinical trial process easier for our competent researchers."
"Clinerion has been dedicated to supporting patients and their physicians in Turkey for many years, and we are pleased to be able to offer our services to even more of the population by welcoming Ege University to our fold," says Ian Rentsch, CEO of Clinerion. "Our strong coverage of the country makes the country itself more attractive to Pharma sponsors and CROs using Patient Network Explorer who are looking to set up trials in the country, as well as offering more statistically meaningful data to researchers."
About Clinerion
Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments.
Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. Researchers gain access to real-time, longitudinal patient data from electronic health records for analysis. We enable pharmaceutical companies, CROs and SMOs to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion's Patient Network Explorer also provides a platform for integration of diverse patient data sources into real-world data ecosystems. Clinerion's proprietary technologies comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion website: http://www.clinerion.com
Clinerion's Patient Network Explorer: http://www.clinerion.com/index/PatientNetworkExplorerSolutions.html
For more information, please contact:
Le Vin Chin
Director, Head of Marketing & Communications
Clinerion Ltd
Elisabethenanlage 11, 4051 Basel, Switzerland
Tel.: +41 61 865 60 54
[email protected]
About Ege University
Ege University Medical Faculty Hospital provides service with its experienced team and rich equipment. Being one of the first two faculties of Ege University, Faculty of Medicine, being in the Aegean Region, provides healing to the Balkans, the Caucasus, and patients from neighboring countries. Ege University Medical Faculty Hospital serves as the largest hospital in the Aegean Region with a bed capacity of 806,000.
Ege University website: https://ege.edu.tr/eng-0/Homepage.html
For more information, please contact:
Academician Levent KONUŞ
Press Relations Manager of Department
Ege University
Tel.: 0232 311 42 99 / Extension no.: 2212
[email protected]
SOURCE Clinerion Ltd.
Share this article